Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Melanoma

Aspirin could hold the key to supercharged cancer immunotherapy

Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment

Science Snaps: bridging the gap between nerve repair and cancer spread

This entry is part 13 of 13 in the series Science Snaps

Thanks to the dexterity of surgeons it’s now possible to reattach severed fingers, toes and even limbs that have...

NHS England must act as patients miss out on cancer drug tests

It’s a wonder of modern science that, for at least some types of cancer, doctors are now able to exploit the unique genetic faults in a person’s tumour to treat their...

5 hot research topics our scientists are homing in on

From the mechanics behind fast-moving melanoma cells to cancer’s very own (and very complex) family tree, we’ve picked a handful of important research discoveries to share...

ASCO 2015 round-up: immunotherapy continues to come of age

As you’ll have probably spotted by the array of cancer stories in the media over the last week, the world’s biggest annual cancer conference has just taken place.

...

Virus therapy for melanoma – all it’s cracked up to be?

If you’ve seen the news today, you’ve probably seen stories about a new ‘virotherapy’ for advanced melanoma.

On the face of it, this is exciting news. Researchers...

Immunotherapy drugs show continued promise

A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference.

Immunotherapy drug combination shows promise for advanced melanoma patients

Two immunotherapy drugs could be better than one - at least for a subset of patients with advanced melanoma.

Science Snaps: exposing melanoma’s ‘safe haven’ to help tackle drug resistance

This entry is part 11 of 11 in the series Science Snaps

Drug resistance is a big problem, particularly for advanced melanoma.

People with melanoma respond well...

Melanoma’s ‘safe haven’ targeted for shut-down

Melanoma cells become drug resistant by using surrounding healthy cells to provide a ‘safe haven’ from treatment reveals new research published in Cancer Cell.

Pages